Highlights
NASDAQ: EIGR       Eiger Biopharma
Last Price Today's Change   Day's Range   Trading Volume
10.16   +0.02 (0.20%)  9.65 - 10.27  447,500

Overview

 
Avg Volume (4 weeks):605,914
4 Weeks Range:7.57 - 10.62
4 Weeks Price Volatility (%):
84.92%
52 Weeks Range:4.55 - 15.82
52 Weeks Price Volatility (%):
49.78%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases. The company’s pipeline includes five Phase 2 development programs addressing four distinct orphan diseases. The pipeline includes lonafarnib for Hepatitis Delta Virus, or HDV, PEG-interferon lambda-1a (lambda) for HDV, exendin 9-39 for Post-Bariatric Hypoglycemia, or PBH and ubenimex for Pulmonary Arterial Hypertension, or PAH and lymphedema.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3796  4588  642  217 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CBLI 3.17+1.00 
 WEI 5.13+4.311 
 AAPL 117.51+1.53 
 HTZ 1.84-0.33 
 ACOR 0.962+0.272 
 NIO 27.96+0.33 
 GE 7.34+0.05 
 SQQQ 21.69-0.16 
 OAS 0.155-0.014 
 DKNG 42.53-2.05